Cassier, P. A., Italiano, A., Gomez-Roca, C. A., Le Tourneau, C., Toulmonde, M., Cannarile, M. A., Ries, C., Brillouet, A., Müller, C., Jegg, A., Bröske, A., Dembowski, M., Bray-French, K., Freilinger, C., Meneses-Lorente, G., Baehner, M., Harding, R., Ratnayake, J., Abiraj, K., Gass, N., Noh, K., Christen, R. D., Ukarma, L., Bompas, E., Delord, J., Blay, J., & Rüttinger, D. (n.d.). cSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Lancet oncology, 16(8), 949–956. http://access.bl.uk/ark:/81055/vdc_100050933075.0x000018